Health and Healthcare
Biotech Short Interest (May 2007) (AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD)
Published:
Stock Tickers: AMGN, GILD, CELG, GENZ, MEDI, BIIB, AMLN, IMCL, DNDN, NFLD
The short interest is on the rise overall, but the odd thing is that the short interest in biotech shares is really a mixed bag. Some of the short interest indications doesn’t really look like the short sellers were making the right moves, but time will be the true judge. Here are the key NASDAQ biotech short interest numbers:
Stock (Ticker MAY APRIL CHANGE
Amgen (AMGN) 25.59M 27.99M -8.5%
Gilead (GILD) 12.99M 13.57M -4.2%
Celgene (CELG) 25.9M 24.6M 5%
Genzyme (GENZ) 7.05M 6.75M 4.5%
Medimmune (MEDI) 20.5M 17.2M 18.8%
Biogen-Idec (BIIB) 9.61M 9.09M 5.7%
Amylin Pharma (AMLN) 18.7M 20.0M -6.4%
Imclone (IMCL) 6.26M 7.89M -20.6%
Dendreon (DNDN) 41.6M 33.9M 22.9%
Northfield (NFLD) 6.24M 6.62M -5.7%
Jon C. Ogg
May 25, 2007
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
